Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hematological manifestations and complications of Gaucher disease
Shoshana Revel‐Vilk, Jeff Szer, Ari Zimran
Expert Review of Hematology (2021) Vol. 14, Iss. 4, pp. 347-354
Closed Access | Times Cited: 21

Showing 21 citing articles:

Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease
Mia Horowitz, Hila Braunstein, Ari Zimran, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114402-114402
Closed Access | Times Cited: 38
Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?
Tama Dinur, Peter Bauer, Christian Beetz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1627-1627
Open Access | Times Cited: 25
Emerging biomarkers in Gaucher disease
Danielle M Luettel, Márcia R. Terluk, Jaehyeok Roh, et al.
Advances in clinical chemistry (2025), pp. 1-56
Closed Access
Rare biochemical & genetic conditions: clues for broader mechanistic insights
Alexios‐Fotios A. Mentis, Μaria Dalamaga
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Inhibition of microglial β-glucocerebrosidase hampers the microglia-mediated antioxidant and protective response in neurons
Electra Brunialti, Alessandro Villa, Marianna Mekhaeil, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 19
A review of type 3 Gaucher disease: unique neurological manifestations and advances in treatment
Wei Zhong, Dan Li, Yue Fei, et al.
Acta Neurologica Belgica (2024) Vol. 124, Iss. 4, pp. 1213-1223
Closed Access | Times Cited: 2
Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease
Tama Dinur, Peter Bauer, Christian Beetz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3945-3945
Open Access | Times Cited: 6
A Deep-Learning Approach to Spleen Volume Estimation in Patients with Gaucher Disease
Ido Azuri, Ameer Wattad, Keren Peri-Hanania, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5361-5361
Open Access | Times Cited: 3
Enzyme replacement therapy leading to improvement in myeloma indices in a patient with concomitant Gaucher disease
Reut Harel, Israel Gavish, Ariel Aviv, et al.
Internal Medicine Journal (2022) Vol. 52, Iss. 5, pp. 872-875
Closed Access | Times Cited: 5
Novel Management and Screening Approaches for Haematological Complications of Gaucher’s Disease
Pilar Giraldo, Marcio Andrade‐Campos
Journal of Blood Medicine (2021) Vol. Volume 12, pp. 1045-1056
Open Access | Times Cited: 7
Platelet Activation and Reactivity in a Large Cohort of Patients with Gaucher Disease
Shoshana Revel‐Vilk, Mira Naamad, Dafna Frydman, et al.
Thrombosis and Haemostasis (2021) Vol. 122, Iss. 06, pp. 951-960
Closed Access | Times Cited: 6
The Complexities of Diagnosis with Co-Existing Gaucher Disease and Hemato-Oncology—A Case Report and Review of the Literature
Paulina Suduł, Beata Piątkowska‐Jakubas, Łukasz Pawliński, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5518-5518
Open Access | Times Cited: 2
Cancer Risk in Patients with Gaucher Disease Using Real-World Data
Shoshana Revel‐Vilk, Ari Zimran, Majdolen Istaiti, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7707-7707
Open Access | Times Cited: 2
Blood cytopenias as manifestations of inherited metabolic diseases: a narrative review
Yannick Moutapam-Ngamby—Adriaansen, F. Maillot, F. Labarthe, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access
[Genetic characteristics and clinical analysis of 20 patients with Gaucher's disease].
T B Zhang, Xiaohui Wen, Xianlong Zhang, et al.
PubMed (2024) Vol. 45, Iss. 1, pp. 82-85
Closed Access
СЛУЧАЙ ПРОГРЕССИРОВАНИЯ БОЛЕЗНИ ГОШЕ ПРИ ДЛИТЕЛЬНОМ ЛЕЧЕНИИ ИМИГЛЮЦЕРАЗОЙ
А.А. Амангельдиева, Р.З. Боранбаева, G. Abdilova
Farmaciâ Kazahstana (2024), Iss. 3, pp. 150-157
Open Access
Diagnosis and management of patients with Gaucher disease: an Egyptian expert opinion
Amal El‐Beshlawy, Azza Abdel Gawad Tantawy, Rabah M. Shawky, et al.
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access
Recent Therapeutic Advancements for Gaucher Disease
Lipi Pradhan, Sumit Manna, Pragya Pragya, et al.
Advanced Therapeutics (2024) Vol. 8, Iss. 1
Open Access
An Overview of Gaucher Disease
Daniela Anahí Méndez-Cobián, Sandra Guzmán-Silahua, Diana García-Hernández, et al.
Diagnostics (2024) Vol. 14, Iss. 24, pp. 2840-2840
Open Access
Simultaneous Bilateral Femoral Osteonecrosis in Gaucher Disease
Daniel Cohen, Yadin Levy, Yaron Bar-Ziv, et al.
Life (2023) Vol. 13, Iss. 5, pp. 1135-1135
Open Access | Times Cited: 1
Brain-Derived Neurotrophic Factor (BDNF) Is Associated with Platelet Activity and Bleeding Tendency in Patients with Gaucher Disease
David Azoulay, Mira Naamad, Dafna Frydman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13982-13982
Open Access | Times Cited: 1
Page 1

Scroll to top